author-photo

Sy Amy Cheung

AstraZeneca

3

Papers

27

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Results of two Phase 1 multicenter trials of AZD5363, an inhibitor of AKT1, 2 and 3: biomarker and early clinical evaluation in Western and Japanese patients with advanced solid tumors.

2013
Show All
- Source
- Cite
- Save
Citations (2)